期刊文献+

肺炎衣原体诱发肺癌模型的建立

Study on Lung Cancer Model Induced by Chlamydia Pneumoniae
下载PDF
导出
摘要 目的:建立肺炎衣原体(Chlamydia pneumoniae,Cpn)诱发大鼠肺癌模型。方法:采用Cpn菌株TW-183感染的方法以及TW-183感染联合苯并芘(Benzopyrene,Bp)的方法建立肺癌Wistar大鼠模型。采用微量免疫荧光法检测大鼠血清中Cpn特异性抗体,采用聚合酶链式反应的方法检测大鼠肺癌组织中的Cpn DNA,采用酶联免疫吸附法检测大鼠肺癌组织中的Cpn特异性抗原。结果:单独Cpn感染大鼠的Cpn感染率为72.9%(35/48),Cpn感染联合Bp大鼠的Cpn感染率为76.7%(33/43);两组的肺癌发生率分别为14.6%(7/48)和44.2%(19/43),均显著高于对照小鼠的肺癌发生率(P=0.012,P<0.001)。结论:本研究成功建立Cpn感染诱发大鼠肺癌模型。 Objective: To build a rat model of lung cancer induced by Chlamydia pneumoniae(Cpn) infection. Methods: Cpn (TW 183) was injected into the lungs of the rats with or without the combination of Benzopyrene(Bp). Cpn-antibodies(Cpn- IgA, -IgG and -IgM) in rat serum were detected by the method of microimmunofluorescence(MIF). The Cpn-DNA and Cpw Ag in lung cancer tissues were detected by polymerase chain reaction(PCR)and enzyme-linked immunosorbent assay(ELISA), respectively. Results: The incidences of Cpn infection were 72.9 % (35/48) in rats injected with Cpn and 76.7% (33/43) in rats injected with Cpn and Bp; and the incidences of lung cancer in them were 14.6%(7/48) and 44.2%(19/43) , respectively, all of which were significantly higher than the controls(P = 0. 012, P〈0. 001, respectively). Conclusions: A rat model of lung cancer induced by Chlamydia pneumoniae infection has been successfully built.
出处 《中国临床医学》 2012年第3期204-206,共3页 Chinese Journal of Clinical Medicine
基金 上海市科委基金项目(编号:09411966300)
关键词 肺炎衣原体 苯并芘 肺癌 动物模型 Chlamydia pneumoniae Benzopyrene Lung cancer Animal model
  • 相关文献

参考文献12

  • 1Zhan P, Suo LJ, Qian Q, et al. Chlamydia pneumoniae infec- tion and lung cancer risk: A meta-analysis[J]. Eur J Cancer, 2011, 47(5) :742-747.
  • 2罗素琼,刘学泽,王朝俊.青石棉,苯并(a)芘联合诱发大鼠肺癌的研究[J].华西医科大学学报,1995,26(2):202-205. 被引量:4
  • 3Fan P, Dong F, Huang Y, et al. Chlamydia pneumoniae se erection of a proteases-like activity factor for degrading host cell transcription factor required for major histoeompatihility complex antigen expression[J]. Infection Immunity, 2002, 70(1) :345-349.
  • 4Lin CY, Su SB, Chang CC, et al. The association between Chlamydia pneumoniae and metabolic syndrome in Taiwan Residents adults[J]. South Med J, 2009,102(12):1203-1208.
  • 5Chaturvedi AK, Gaydos CA, Agreda P, et al. Chlamydia pneumoniae infection and risk for lung cancer[J]. Cancer Epi- demiol Biomarkers Prev, 2010,19(6) : 1498-1505.
  • 6Littman AJ, Jackson LA, Vaughan TL. Chlamydia pneumon- iae and lung cancer: epidemiologic evidence[J]. Cancer Epi demiol Biomarkers Prey, 2005,14(4) :773-778.
  • 7Littman AJ, White E, Jackson LA, et al. Chlamydia pneu- moniae infection and risk of lung cancer[J]. Cancer Epidemiol Biomarkers Prev, 2004,13(10) : 1624-1630.
  • 8Anttila T, Koskela P, Leinonen M, et al. Chlamydia pneu moniae infection and the risk of female early-onset lung cancer [J]. Int J Cancer, 2(103,107(4) :681-682.
  • 9Kocazeybek B. Chronic Chlamydophila pneumoniae infection in lung cancer, a risk factor: a case control study[J]. J Med Microbiol, 2003,52(Pt 8) :721-726.
  • 10Smith JS, Kumlin U, Nyberg F, et al. Lack of association between serum antibodies of Chlamydia pneumoniae infection and the risk of lung cancer[J]. Int J Cancer, 2008,123(10) : 2469-2471.

二级参考文献3

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部